FGF23 and risk of all-cause mortality and cardiovascular events: a meta-analysis of prospective cohort studies

Int J Cardiol. 2014 Oct 20;176(3):1341-2. doi: 10.1016/j.ijcard.2014.07.142. Epub 2014 Aug 2.

Authors

Karl Krupp¹, Purnima Madhivanan²

Affiliations

¹ Robert Stempel College of Public Health & Social Work, Florida International University, Miami, USA.
² Robert Stempel College of Public Health & Social Work, Florida International University, Miami, USA. Electronic address: pmadhiva@fiu.edu.

PMID: 25115265
DOI: 10.1016/j.ijcard.2014.07.142

No abstract available

Keywords: Cardiovascular disease; Cohort studies; Fibroblast growth factor 23; Meta-analysis.

Publication types

Letter
Comment

MeSH terms

Cardiovascular Diseases / blood*
Cardiovascular Diseases / mortality*
Fibroblast Growth Factor-23
Fibroblast Growth Factors / blood*
Humans

Substances

FGF23 protein, human
Fibroblast Growth Factors
Fibroblast Growth Factor-23